Invention Grant
- Patent Title: Fused heterocyclyc inhibitor compounds
- Patent Title (中): 融合的杂环基抑制剂化合物
-
Application No.: US12502967Application Date: 2009-07-14
-
Publication No.: US08124764B2Publication Date: 2012-02-28
- Inventor: Lawrence S. Melvin, Jr. , Michael Graupe , Chandrasekar Venkataramani
- Applicant: Lawrence S. Melvin, Jr. , Michael Graupe , Chandrasekar Venkataramani
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent J. Elin Hartrum; Francis O. Ginah
- Main IPC: C07D401/00
- IPC: C07D401/00
Abstract:
The present invention provides a compound of general Formula (I) having histone deacetylase (HDAC) and/or Cyclin-dependent kinase (CDK) inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound.
Public/Granted literature
- US20100029638A1 FUSED HETEROCYCLYC INHIBITOR COMPOUNDS Public/Granted day:2010-02-04
Information query
